Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Glucocorticoids are among the most common therapeutic agents used in medical practice, yet their mechanisms of action are only partly understood. This review summarizes our understanding of how glucocorticoids inhibit inflammation and give rise to side effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NLRP3 inflammasome upregulation and caspase-mediated cleavage of the glucocorticoid receptor can cause resistance to the effects of glucocorticoids, which are among the most potent anti-inflammatory hormones in the body46,47.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [47]
In the citing paper
“HPA axis activation and subsequent secretion of glucocorticoids in response to stressor exposure typically acts to prevent pro-inflammatory activity via inhibition of NFκB (Rhen and Cidlowski, 2005).”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Rhen and Cidlowski, 2005
In the citing paper
“cortisol is one of the most potent anti-inflammatory hormones in the body.9”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [9]
In the citing paper
“major depression is a disorder that is characterized by hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis and increased release of glucocorticoids”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [9]
In the citing paper
“Corticosteroids (e.g., methylprednisolone, prednisolone, prednisone) are commonly used immunosuppressants for their global inhibitory effects on innate and adaptive immunity (36).”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [36]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Retracted: Effects of Vitamin K2 on Osteoporosis
Iwamoto, J., Takeda, T., & Satō, Y. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383782 · Cited by 66
RetractedAngus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Epidemiology and estimated population burden of selected autoimmune diseases in the United States
Jacobson, D. L., Gange, S. J., Rose, N. R., & Graham, N. M. H. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4412 · Cited by 1,667
Regulation of matrix metalloproteinases: An overview
Chakraborti, S., Mandal, M., Das, S., Mandal, A., & Chakraborti, T. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1026028303196 · Cited by 1,128
Neuroendocrine Regulation of Immunity
Webster, J. I., Tonelli, L., & Sternberg, E. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.082401.104914 · Cited by 957
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
Research works printed but not linked: 4
- Rhen T, Cidlowski JA. Steroid hormone action. In: Strauss JF III, Barbieri RL, eds. Yen and Jaffe's reproductive endocrinology. 5th ed. Philadelphia: Elsevier Saunders, 2004:155-74.
- 10.1210/mend.15.7.0667 · doi:10.1210/mend.15.7.0667 · Paper page
- Roviezzo F, 2002, J Physiol Pharmacol, 53, 541
- Mitch WE, 2000, Trans Am Clin Climatol Assoc, 111, 258
Cited by
Items 401–500 of 1,016
Immunosuppressive Agents: Effects on Glucose and Lipid Metabolism
Subramanian, S., & Trence, D. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.07.003 · Cited by 85
Structural insights into the role of the Smoothened cysteine-rich domain in Hedgehog signalling
Rana, R., Carroll, C. E., Lee, H., Bao, J., Marada, S., Grace, C. R., Guibao, C. D., Ogden, S. K., & Zheng, J. (2013) · Nature Communications · doi:10.1038/ncomms3965 · Cited by 90
Personalized medicine—concepts, technologies, and applications in inflammatory skin diseases
Litman, T. (2019) · Apmis · doi:10.1111/apm.12934 · Cited by 96
“These effects are brought about via several mechanisms: non-genomic direct activation of antiinflammatory proteins, DNA-dependent (genomic) induction of anti-inflammatory proteins, and protein interference (via transcription factors, such as NF-jB) causing repression of inflammatory proteins (4, 5).”
BackgroundAutry, R. J., Paugh, S. W., Carter, R., Shi, L., Liu, J., Ferguson, D. C., Lau, C. E., Bonten, E. J., Yang, W., McCorkle, J. R., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0037-3 · Cited by 85
Role of interstitial inflammation in the pathogenesis of polycystic kidney disease
Ta, M. H. T., Harris, D. C. H., & Rangan, G. K. (2013) · Nephrology · doi:10.1111/nep.12045 · Cited by 93
Androgen–glucocorticoid interactions in the era of novel prostate cancer therapy
Narayanan, S., Srinivas, S., & Feldman, D. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.254 · Cited by 90
Gumy, C., Chandsawangbhuwana, C., Dzyakanchuk, A., Kratschmar, D., Baker, M., & Odermatt, A. (2008) · Nature Precedings · doi:10.1038/npre.2008.2312.1 · Cited by 81
Nicolaides, N. C., Charmandari, E., Chrousos, G. P., & Kino, T. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-71 · Cited by 83
“However, a number of patients are often resistant to treatment with glucocorticoids [1-4].”
BackgroundInfluentialKüng, D., Bigler, L., Davis, L. R., Gratwicke, B., Griffith, E., & Woodhams, D. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087101 · Cited by 83
“Stressors may also differ among sites, and long-term upregulation of stress hormones including glucocorticoids can suppress immunity [75] including AMP skin defenses in amphibians [76].”
BackgroundSoriano, A., Soriano, M., Espinosa, G., Manna, R., Emmi, G., Cantarini, L., & Hernández‐Rodríguez, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00865 · Cited by 91
“Consequently, the activated glucocorticoid receptor–glucocorticoid complex up-regulates the expression of anti-inflammatory proteins and suppresses the transcription of proinflammatory cytokines and chemokines by blocking the NF-κB signaling pathway (52).”
BackgroundEffect of Quercetin on Dexamethasone-Induced C2C12 Skeletal Muscle Cell Injury
Chen, C., Yang, J., Lu, C., Chiu, Y., Chen, H., Chung, M., Wu, Y., & Chen, F. (2020) · Molecules · doi:10.3390/molecules25143267 · Cited by 88
Hu, W., Zhang, Y., Wu, W., Yin, Y., Huang, D., Wang, Y., Li, W., & Li, W. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.09.019 · Cited by 90
“However, a long term therapy with GCs has been linked to memory impairment, anxiety disorders, depression, and other systemic toxicity, such as osteoporosis, hyperglycaemia, electrolyte abnormalities, and hypertension (Crosby and Bains, 2012; Rhen and Cidlowski, 2005).”
BackgroundTNF ‐α: a treatment target or cause of sarcoidosis?
Amber, K. T., Bloom, R., Mrowietz, U., & Hertl, M. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13246 · Cited by 85
Dissanayake, R., Du, H. N., Robertson, I. K., Ogden, K., Wiltshire, K., & Mulford, J. (2018) · The Journal of Arthroplasty · doi:10.1016/j.arth.2018.07.013 · Cited by 85
Why Hasn't Eliminating Acute Rejection Improved Graft Survival?
Tantravahi, J., Womer, K. L., & Kaplan, B. E. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.58.061705.145143 · Cited by 83
Probiotics for oral and vulvovaginal candidiasis: A review
Shenoy, A., & Gottlieb, A. (2019) · Dermatologic Therapy · doi:10.1111/dth.12970 · Cited by 59
Autophagy inhibition prevents glucocorticoid-increased adiposity via suppressing BAT whitening
Deng, J., Guo, Y., Yuan, F., Chen, S., Yin, H., Jiang, X., Jiao, F., Wang, F., Ji, H., Hu, G., et al. (2019) · Autophagy · doi:10.1080/15548627.2019.1628537 · Cited by 91
Potential Adverse Effects of Dexamethasone Therapy on COVID-19 Patients: Review and Recommendations
Chen, F., Hao, L., Zhu, S., Yang, X., Shi, W., Zheng, K., Wang, T., & Chen, H. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00500-z · Cited by 89
“In parallel, the antiinflammatory actions of glucocorticoids occur by decreasing the gene transcription of pro-inflammatory cytokines (IL-1, TNF and IL-6), chemokines and adhesion molecules [22].”
BackgroundInhaled corticosteroids for the treatment of COVID-19
Griesel, M., Wagner, C., Mikolajewska, A., Stegemann, M. S., Fichtner, F., Metzendorf, M.-I., Nair, A. A., Daniel, J., Fischer, A.-L., & Skoetz, N. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015125 · Cited by 90
Kassuya, C. A. L., Cremoneze, A., Barros, L. F. L., Simas, A. S., Lapa, F. D. R., de Mello‐Silva, R., Stefanello, M. É. A., & Zampronio, A. R. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.06.003 · Cited by 83
“action by inhibiting of activation of NF B and AP-1 (Rhen and Cidlowski, 2005).”
BackgroundIdentification of Modulators of Hair Cell Regeneration in the Zebrafish Lateral Line
Namdaran, P., Reinhart, K. E., Owens, K. N., Raible, D. W., & Rubel, E. W. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3905-11.2012 · Cited by 82
“Both drugs are thought to act primarily as anti-inflammatory agents, inhibiting macrophage activation and cytokine production (Isobe and Lillehoj, 1992; Hübner et al., 1996; Rhen and Cidlowski, 2005; Schaaf et al., 2009).”
BackgroundAyroldi, E., Macchiarulo, A., & Riccardi, C. (2014) · The FASEB Journal · doi:10.1096/fj.14-254755 · Cited by 86
Nanomedicine for the prevention, treatment and imaging of atherosclerosis
Psarros, C. T., Lee, R., Margaritis, M., & Antoniades, C. A. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.05.006 · Cited by 89
Fontana, L. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2008.04.005 · Cited by 81
“Glucocorticoids have pleiotropic inhibitory effects on the immune system and inflammatory gene expression (Rhen and Cidlowski 2005).”
BackgroundHuang, Y.-L., Kou, J., Ma, L., Song, J., & Yu, B. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08083fp · Cited by 81
Lovato, P., Norsgaard, H., TOKURA, Y., & Røpke, M. A. (2015) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2015.12.009 · Cited by 81
Dry eye syndrome: developments and lifitegrast in perspective
Lollett, I. V., & Galor, A. (2018) · Clinical ophthalmology · doi:10.2147/opth.s126668 · Cited by 88
“Non-genomic effects of corticosteroids also aid in suppressing leukocyte infiltration into areas of inflammation.(111)”
Corticosteroids in management of anaphylaxis; a systematic review of evidence
Liyanage, C. K., Galappatthy, P., & Seneviratne, S. L. (2017) · European Annals of Allergy and Clinical Immunology · doi:10.23822/eurannaci.1764-1489.15 · Cited by 94
Clinical Implications of Inflammation in Acute Myeloid Leukemia
Récher, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.623952 · Cited by 96
“Of course, the main mechanisms of action of GR are in the nucleus (74).”
BackgroundCaillon, A., Trimaille, A., Favre, J., Jesel, L., Morel, O., & Kauffenstein, G. (2021) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15566 · Cited by 89
A systematic review of immunosuppressive protocols used in AAV gene therapy for monogenic disorders
Vrellaku, B., Hassan, I. S., Howitt, R., Webster, C. P., Harriss, E., McBlane, F., Betts, C., Schettini, J. L., Lion, M., Mindur, J. E., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.07.016 · Cited by 84
Ishmael, F. T., Fang, X., Houser, K. R., Pearce, K., Abdelmohsen, K., Zhan, M., Gorospe, M., & Stellato, C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001794 · Cited by 78
“Ligand binding induces conformational changes of the protein complex, leading to disassociation and nuclear translocation of GC, where GR dimerizes and regulates gene transcription (5).”
BackgroundAdžić, M., Djordjevic, J., Mitić, M., Brkic, Z., Lukić, I., & Radojcic, M. B. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.05.029 · Cited by 84
Mocayar Marón, F. J., Ferder, L., Saraví, F. D., & Manucha, W. (2019) · Stress · doi:10.1080/10253890.2018.1542683 · Cited by 73
“…effects of glucocorticoids are: inhibition of nuclear factor- jB s (NF-jB) transcriptional activity, inhibition of prostaglandin production (Rhen & Cidlowski, 2005), and increase the transcription of genes coding for anti-inflammatory proteins, including lipocortin-1, interleukin-10…”
BackgroundBenefits and Risks of Dexamethasone in Noncardiac Surgery
Myles, P. S., & Corcoran, T. B. (2021) · Anesthesiology · doi:10.1097/aln.0000000000003898 · Cited by 85
Wagner, C., Griesel, M., Mikołajewska, A., Metzendorf, M., Fischer, A.-L., Stegemann, M. S., Spagl, M., Nair, A. A., Daniel, J., Fichtner, F., et al. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014963.pub2 · Cited by 96
Glomerular diseases and cancer: evaluation of underlying malignancy
Pani, A., Porta, C., Cosmai, L., Melis, P., Floris, M., Piras, D., Gallieni, M. A., Rosner, M. H., & Ponticelli, C. E. (2015) · Journal of Nephrology · doi:10.1007/s40620-015-0234-9 · Cited by 82
Horita, N., Otsuka, T., Haranaga, S., Namkoong, H., Miki, M., Miyashita, N., Higa, F., Takahashi, H., Yoshida, M., Kohno, S., et al. (2015) · Scientific Reports · doi:10.1038/srep14061 · Cited by 78
New insights into the novel anti-inflammatory mode of action of glucocorticoids
Ingawale, D. K., & Mandlik, S. K. (2020) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2020.1728765 · Cited by 88
“GCs diffuses across the cell membrane and bind to GR in the cytoplasm [30,31].”
BackgroundImpact of Glucocorticoid Use in Oncology in the Immunotherapy Era
Kalfeist, L., Galland, L., Ledys, F., Ghiringhelli, F., Limagne, E., & Ladoire, S. (2022) · Cells · doi:10.3390/cells11050770 · Cited by 84
“For example, GCs can inhibit the signalling of Toll-like receptors (TLRs) at several levels, namely by binding the GCs ligand receptors leading to inhibition of transcription factors, such as NF-κB, activator protein 1 (AP1), or IRF3.”
BackgroundInfluentialSheng, M., Chen, Y., Li, H., Zhang, Y., & Zhang, Z. (2023) · Burns & Trauma · doi:10.1093/burnst/tkad009 · Cited by 82
Dominance of the strongest: Inflammatory cytokines versus glucocorticoids
Dejager, L., Vandevyver, S., Πέττα, Ι., & Libert, C. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.12.006 · Cited by 85
“Thus, GR mediates either positive or negative transcriptional events, which together culminate in coordinated anti-inflammatory actions [1,2].”
BackgroundEffects of inhaled fluticasone on angiogenesis and vascular endothelial growth factor in asthma
Feltis, B., Wignarajah, D., Reid, D. W., Ward, C., Harding, R., & Walters, E. H. (2007) · Thorax · doi:10.1136/thx.2006.069229 · Cited by 85
“Inhaled corticosteroids (ICS) are the most effective therapy currently available for inducing symptomatic control, and have become the mainstay of modern asthma therapy [1].”
Backgroundα,β-amyrin, a natural triterpenoid ameliorates L-arginine-induced acute pancreatitis in rats
Melo, C. M. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i34.4272 · Cited by 78
Malemud, C. J., & Miller, A. H. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.2.171 · Cited by 78
“Given the role of glucocorticoids in dampening inflammatory responses (largely through protein-protein interactions with relevant inflammatory signaling transcription factors such as NFκ B), impaired glucocorticoid feedback regulation may also contribute to ongoing inflammation [88] .”
BackgroundAvailable Therapeutic Options for Corneal Neovascularization: A Review
Drzyzga, Ł. R., Śpiewak, D., Dorecka, M., & Wyględowska‐Promieńska, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105479 · Cited by 89
Vitamin D Enhances Glucocorticoid Action in Human Monocytes
Zhang, Y., Leung, D. Y. M., & Goleva, E. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.427054 · Cited by 83
Hoffman, E. P., Riddle, V., Siegler, M. A., Dickerson, D., Bačkonja, M., Kramer, W. G., Nagaraju, K., Gordish‐Dressman, H., Damsker, J. M., & McCall, J. M. (2018) · Steroids · doi:10.1016/j.steroids.2018.02.010 · Cited by 80
“from release from peripheral tissues, whereas loss of lymphocytes is due to induction of apoptosis [3,31].”
BackgroundCao, Y., Bender, I. K., Konstantinidis, A. K., Shin, S. C., Jewell, C. M., Cidlowski, J. A., Schleimer, R. P., & Lu, N. Z. (2013) · Blood · doi:10.1182/blood-2012-05-432336 · Cited by 76
“Upon activation by glucocorticoids, GR mainly acts at the transcriptional level to suppress the expression of proinflammatory genes and to induce antiinflammatory genes.(6) Different GR isoforms have different sets of gene targets.”
Self-citationHolmes, L., Shutman, E., Chinaka, C., Deepika, K., Pelaez, L., & DABNEY, K. W. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16214280 · Cited by 84
“The receptor–cortisol complex effectively works to decrease inflammation in tissues by either upregulating the expression of anti-inflammatory proteins in the nucleus or by repressing the expression of pro-inflammatory proteins in the cytosol [19].”
BackgroundCavalcanti, D. M. D. H., Lotufo, C. M. C., Borelli, P., Ferreira, Z. S., Markus, R. P., & Farsky, S. H. P. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707512 · Cited by 76
“In addition to the effects exerted by endogenous hormones, synthetic hormones are important therapeutic tools for the treatment of inflammatory diseases and as immunosuppressor agents (Rhen and Cidlowski, 2005; Song et al., 2005).”
BackgroundNeuroendocrine Effects of Stress on Immunity in the Elderly: Implications for Inflammatory Disease
Heffner, K. L. (2011) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2010.09.005 · Cited by 77
“Finally, glucocorticoid resistance in certain inflammatory diseases, such as steroid-resistant asthma, rheumatoid arthritis, and inflammatory bowel disease, is well-documented.(59,60)”
BackgroundDesigning Safer Analgesics via μ-Opioid Receptor Pathways
Chan, H. C. S., McCarthy, D. R., Li, J., Palczewski, K., & Yuan, S. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.08.004 · Cited by 81
“Meanwhile, both the complex monomers and dimers bind to nuclear factor-κB elements on DNA, inhibiting the expression of proinflammatory cytokines (transrepression) [73].”
BackgroundLauber, K., Keppeler, H., Munoz, L. E., Koppe, U., Schröder, K., Yamaguchi, H., Krönke, G., Uderhardt, S., Wesselborg, S., Belka, C., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.82 · Cited by 77
“used medications for the treatment of inflammatory diseases, some of these reportedly associated with delays and defects in apoptotic cell clearance.(4,5,18,28) To date, the anti-phlogistic effects of GCs principally are considered to be caused by GRmediated transrepression of pro-inflammatory cytokines.”
MethodDexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence
Sharun, K., Tiwari, R., Dhama, J., & Dhama, K. (2020) · International Journal of Surgery · doi:10.1016/j.ijsu.2020.08.038 · Cited by 75
“Corticosteroids such as dexamethasone possess anti-inflammatory potential because of their ability to decrease the gene transcription of several pro-inflammatory cytokines, chemokines, and adhesion molecules [5].”
BackgroundXu, Y., Gu, Y., Cai, F., Xi, K., Xin, T., Tang, J., Wu, L., Wang, Z., Wang, F., Deng, L., et al. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202006333 · Cited by 75
Role of Lung Microbiome in Innate Immune Response Associated With Chronic Lung Diseases
Paudel, K. R., Dharwal, V., Patel, V. K., Galvão, I., Wadhwa, R., Malyla, V., Shen, S., Budden, K. F., Hansbro, N. G., Vaughan, A., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00554 · Cited by 84
“The main therapy for asthma includes anti-inflammatory corticosteroids, which are generally administered in combination with short- or long-acting β2-adrenoceptor agonists (bronchodilators) (24, 189).”
BackgroundLayered Double Hydroxides: A Novel Promising 2D Nanomaterial for Bone Diseases Treatment
Bian, Y., Cai, X., Lv, Z., Xu, Y., Wang, H., Tan, C., Liang, R., & Weng, X. (2023) · Advanced Science · doi:10.1002/advs.202301806 · Cited by 83
Mountziaris, P. M., Tzouanas, S. N., & Mikos, A. G. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.058 · Cited by 75
Alpha and beta glucocorticoid receptors: Relevance in airway diseases
Pujols, L., Mullol, J., & Picado, C. (2007) · Current Allergy and Asthma Reports · doi:10.1007/s11882-007-0005-3 · Cited by 85
Adenuga, D., & Rahman, I. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.04.002 · Cited by 76
Chivers, J. E., Gong, W., King, E. M., Seybold, J., Mak, J. C., Donnelly, L. E., Holden, N. S., & Newton, R. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025841 · Cited by 74
“However, ligand-activated GR may also inhibit, or transrepress, transcription factors such as nuclear factor- B (NFB) and activator protein-1 (AP-1) via processes that are believed to be independent of GR dimerization and GR DNA binding (Barnes, 2001; Rhen and Cidlowski, 2005).”
BackgroundInfluentialCole, S. W., Mendoza, S. P., & Capitanio, J. P. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181aa95a9 · Cited by 74
Regulation of Lung Epithelial Sodium Channels by Cytokines and Chemokines
Wynne, B. M., Zou, L., Linck, V., Hoover, R. S., Ma, H., & Eaton, D. C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00766 · Cited by 75
“The positive effects of corticosteroid therapy lie in the ability of the GR to bind to and inhibit nuclear factor kappa-light-chain-enhancer of activated B cells (Nf-κ B) (46–48).”
BackgroundCortisol excess in chronic kidney disease – A review of changes and impact on mortality
Sagmeister, M. S., Harper, L., & Hardy, R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1075809 · Cited by 93
“In turn, glucocorticoids exert potent immunosuppressive actions (7).”
BackgroundBryan, J., Frank, L. A., Rohrbach, B. W., Burgette, L. J., Cain, C. L., & Bemis, D. A. (2012) · Veterinary Dermatology · doi:10.1111/j.1365-3164.2012.01034.x · Cited by 74
Ha, Y., Lee, K.-H., Jung, S., Lee, S.-W., Lee, S., & Park, Y.-B. (2011) · Lupus · doi:10.1177/0961203311402246 · Cited by 78
Glucocorticoid-Refractory Acute Graft-versus-Host Disease
Pidala, J., & Anasetti, C. (2010) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2010.01.007 · Cited by 75
“Basic work has elucidated the major mechanisms of glucocorticoid action, including activation of anti-inflammatory genes, as well as suppression of activated inflammatory genes [18,19], and molecular mechanisms of glucocorticoid refractoriness have been determined.”
BackgroundMeintjes, G., Skolimowska, K. H., Wilkinson, K. A., Matthews, K., Tadokera, R., Conesa-Botella, A., Seldon, R., Rangaka, M. X., Rebe, K. B., Pepper, D. J., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201201-0094oc · Cited by 74
“Corticosteroids are known to exert antiinflammatory effects on immune cells through direct effects on transcription of inflammatory mediators via the glucocorticoid-responsive element, indirect genomic effects via interference with other transcriptional factors such as NF-kB and AP-1, and nongenomic effects on antiinf…”
BackgroundMarinelli, O., Iannarelli, R., Beatrice, M. M., Matteo, V., Nicotra, G., Amantini, C., Cardinali, C., Santoni, G., Maggi, F., & Nabissi, M. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.06.024 · Cited by 79
Bose, S. K., Hutson, I., & Harris, C. A. (2016) · Endocrinology · doi:10.1210/en.2016-1615 · Cited by 79
Kurata, M., Rathe, S. K., Bailey, N. J., Aumann, N. K., Jones, J. M., Veldhuijzen, G. W., Moriarity, B. S., & Largaespada, D. A. (2016) · Scientific Reports · doi:10.1038/srep36199 · Cited by 74
Mitochondrial determinants of cancer health disparities
Choudhury, A. R., & Singh, K. K. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.05.001 · Cited by 79
The Use of Glucocorticoids in Lupus Nephritis: New Pathways for an Old Drug
Mejia-Vilet, J. M., & Ayoub, I. M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.622225 · Cited by 80
“Two of their most important effects are their strong anti-inflammatory and immunosuppressive effects, evident at concentrations above the physiological glucocorticoid levels (6).”
BackgroundHaugeberg, G., Helgetveit, K., Førre, Ø., Garen, T., Sommerseth, H., & Prøven, A. (2014) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-15-289 · Cited by 79
“GCs are known as potent anti-inflammatory drugs and are frequently used in RA, however, they also cause osteoporosis [20,21].”
BackgroundNaji, A., Muzembo, B. A., Yagyu, K.-I., Baba, N., Deschaseaux, F., Sensebé, L., & Suganuma, N. (2016) · Scientific Reports · doi:10.1038/srep26162 · Cited by 73
Catecholamine physiology and its implications in patients with COVID-19
Gubbi, S., Nazari, M. A., Taïeb, D., Kłubo-Gwieździńska, J., & Pacák, K. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30342-9 · Cited by 77
Stifel, U., Wolfschmitt, E.-M., Vogt, J. A., Wachter, U. A., Vettorazzi, S., Tews, D., Hogg, M., Zink, F., Koll, N., Winning, S., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101424 · Cited by 81
“GR activates various anti-in fl ammatory genes such as Gilz ( Tsc22d3 ) and Dusp1 [7,8] while repressing the expression of pro-in fl ammatory cytokines, e.g. Tnf [9].”
Chalmers, S. J., Khawaja, A. I., Wieruszewski, P. M., Gajic, O., & Odeyemi, Y. (2019) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v8.i5.74 · Cited by 93
Circulating MicroRNAs and Treatment Response in Childhood Asthma
Li, J., Panganiban, R. A. M., Kho, A. T., McGeachie, M. J., Farnam, L., Chase, R., Weiss, S. T., Lu, Q., & Tantisira, K. G. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201907-1454oc · Cited by 74
Bronchopulmonary dysplasia: Clinical perspective
Jain, D., & Bancalari, E. H. (2014) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.23229 · Cited by 72
Schwartze, J. T., Becker, S., Sakkas, E., Wujak, Ł. A., Niess, G., Usemann, J., Reichenberger, F., Herold, S., Vadász, I., Mayer, K., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.541052 · Cited by 71
“In this way, glucocorticoids influence a broad spectrum of physiological processes, including fat, protein and carbohydrate metabolism, and inflammation (1, 2).”
BackgroundImmune modulatory therapies for spinal cord injury – Past, present and future
Plemel, J. R., Yong, V. W., & Stirling, D. P. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.01.025 · Cited by 79
Vaccination of neonates: Problem and issues
Hodgins, D. C., & Shewen, P. E. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.12.047 · Cited by 84
The Use of Topical Corticosteroids for Treatment of Dry Eye Syndrome
Cutolo, C. A., Barabino, S., Bonzano, C., & Traverso, C. E. (2017) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2017.1341988 · Cited by 72
“Whereas CsA exerts its primary therapeutic effect by inhibiting the activation of T cells,(18) corticosteroids cause inhibitory mechanism on a broad range of specific immune responses mediated by T cells, B cells, and potent suppressive effects on the production of proinflammatory cytokines.(19,20) Recently, the US Fo…”
BackgroundAhmed, A. S., Schmidt, C., & Brunner, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01438 · Cited by 75
“gene transcription by direct DNA-binding or by interaction with other proteins (3, 37).”
BackgroundInfluentialGandhi, Y., Kumar, R. A., Grewal, J., Rawat, H., Mishra, S. K., Kumar, V. L., Shakya, S. K., Jain, V., Babu, G., Sharma, P., et al. (2022) · Food Chemistry Advances · doi:10.1016/j.focha.2022.100085 · Cited by 80
Crosstalk between TNF and glucocorticoid receptor signaling pathways
Bogaert, T. V., Bosscher, K. D., & Libert, C. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.04.003 · Cited by 80
“formation, mood and drug addiction [12,13].”
Mechanisms and clinical consequences of critical illness associated adrenal insufficiency
Marik, P. E. (2007) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32818a6d74 · Cited by 76
Smans, L. C. C. J., Souverein, P. C., Leufkens, H. G. M., Hoepelman, A. I. M., & Zelissen, P. M. J. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0879 · Cited by 70
Gudiol, C., Lewis, R. E., Strati, P., & Kontoyiannis, D. P. (2021) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30376-8 · Cited by 72
Orsi, F. A., Lijfering, W. M., Geersing, G., Rosendaal, F. R., Dekkers, O. M., le Cessie, S., & Cannegieter, S. C. (2021) · British Journal of Haematology · doi:10.1111/bjh.17388 · Cited by 75
“allergy, pulmonary, dermatological and rheumatic disorders and malignancies.(1,2) It is wellknown that long-term use of glucocorticoids can cause severe adverse events, e.”
BackgroundXin, W., Zhang, L., Sun, F., Jiang, N., Fan, H., Wang, T., Li, Z., He, J., & Fu, F. (2010) · Phytomedicine · doi:10.1016/j.phymed.2010.08.013 · Cited by 77
Role of Plasminogen Activator Inhibitor-1 in Glucocorticoid-Induced Diabetes and Osteopenia in Mice
Tamura, Y., Kawao, N., Yano, M., Okada, K., Okumoto, K., Chiba, Y., Matsuo, O., & Kaji, H. (2015) · Diabetes · doi:10.2337/db14-1192 · Cited by 73
“Glucocorticoids (GCs) have strong anti-inflammatory properties and are highly effective in the treatment of allergies and inflammatory and autoimmune conditions, such as rheumatoid arthritis, asthma, inflammatory bowel disease, and collagen diseases (1,2).”
BackgroundEfficacy and safety of a novel synergistic drug candidate, CRx-102, in hand osteoarthritis
Kvien, T. K., Fjeld, E., Slatkowsky-Christensen, B., Nichols, M., Zhang, Y., Prøven, A., Mikkelsen, K., Palm, Ø., Borisy, A. A., & Lessem, J. N. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.074401 · Cited by 73
“It has long been a goal to develop a therapeutic agent with the anti-inflammatory and disease modifying activities of corticosteroids without their associated side effects.(17) One approach to creating such a therapeutic agent is to develop a drug combination that contains a glucocorticoid and an enhancing agent that…”
Kleijn, A., Kloezeman, J. J., Treffers-Westerlaken, E., Fulci, G., Leenstra, S., Dirven, C. M. F., Debets, R., & Lamfers, M. L. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097495 · Cited by 70
“Therefore, it is unlikely that dexamethasone negatively influenced viral replication or survival in this model, and it is more probable that the immunosuppressive effects of dexamethasone are responsible for hampering the therapeutic efficacy of Delta24-RGD [38,39].”
BackgroundCorticosteroids and ARDS: A review of treatment and prevention evidence
Khilnani, G., & Hadda, V. (2011) · Lung India · doi:10.4103/0970-2113.80324 · Cited by 70
“[17] 18-20] Considering the fact that inflammation is central to the pathogenesis of ARDS, corticosteroids would be a logical choice for the management of ARDS.”
Siddique, M. I., Katas, H., Amin, M. C. I. M., Ng, S., Zulfakar, M. H., & Jamil, A. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.05.005 · Cited by 75
Donn, R., Berry, A., Stevens, A., Farrow, S., Betts, J., Stevens, R., Clayton, C., Wang, J., Warnock, L., Worthington, J., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-7236com · Cited by 71
“They act through the glucocorticoid receptor, which is ubiquitous ( 1 , 33).”
BackgroundFree Cortisol in Sepsis and Septic Shock
Bendel, S., Karlsson, S., Pettilä, V., Loisa, P., Varpula, M., & Ruokonen, E. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e318172fdba · Cited by 69
“lature, in affecting the distribution of body fluids, and in sensitizing the catecholamine receptors.(5) Adrenal re-”
Background
Metadata
- Authors
- Rhen, T., & Cidlowski, J. A.
- Affiliations
- National Institutes of Health (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-10-20
- Volume
- 353
- Issue
- 16
- Pages
- 1711-1723
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2150691073
- Cited by
- 3,149
- References
- 93
- Citations by year
- 2026: 123 · 2025: 122 · 2024: 152 · 2023: 155 · 2022: 188 · 2021: 220 · 2020: 214 · 2019: 164 · 2018: 153 · 2017: 173 · 2016: 183 · 2015: 176 · 2014: 163 · 2013: 167 · 2012: 136
- FWCI
- 9.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- glucocorticoids, anti-inflammatory mechanism, inflammation, glucocorticoid adverse effects, drug mechanisms of action
- MeSH terms
- Anti-Inflammatory Agents, Glucocorticoids, Humans, Inflammation, Receptors, Glucocorticoid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.